RNA editing has picked up steam in recent years as a potentially safer alternative to gene editing to treat genetic diseases.

On a mission to overcome the dosing challenges posed by radiotherapy, French nanotherapy company Nanobiotix is developing a ...

As Shift Bioscience raises $16 million in seed funding, delve into the field of cellular reprogramming to tackle age-related ...

JAK inhibitors have gained particular attention in the inflammation and immunology (I&I) space, an area that has brought in a wave of investment in recent times. Pharma giants such as Pfizer and ...

Discover advances in epilepsy treatments, innovative solutions for seizure freedom, and challenges in integrating new ...

Discover Booster Therapeutics' novel 20S proteasome activation approach to neurodegenerative diseases as it launches with $15 ...

Find out more about five biomimicry companies harnessing nature’s wisdom to create drug candidates for the benefit of human ...

Starting a biotech company is a daunting journey filled with both challenges and opportunities. Unlike many other industries, the path from idea to market in biotech can be particularly long. To build ...